SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950134-05-001193
Filing Date
2005-01-24
Accepted
2005-01-24 15:42:31
Documents
10

Document Format Files

Seq Description Document Type Size
1 424B3 f02460b3e424b3.htm 424B3 2485475
2 GRAPHIC f02460b3f0246003.gif GRAPHIC 1800
3 GRAPHIC f02460b3f0246004.gif GRAPHIC 2276
4 GRAPHIC f02460b3f0246008.gif GRAPHIC 2928
5 GRAPHIC f02460b3f0246006.gif GRAPHIC 2258
6 GRAPHIC f02460b3f0246000.gif GRAPHIC 7272
7 GRAPHIC f02460b3f0246010.gif GRAPHIC 4020
8 GRAPHIC f02460b3f0246011.gif GRAPHIC 3916
9 GRAPHIC f02460b3f0246001.gif GRAPHIC 2528
10 GRAPHIC f02460b3f0246002.gif GRAPHIC 3804
  Complete submission text file 0000950134-05-001193.txt   2518794
Mailing Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545
Business Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-120101 | Film No.: 05544386
SIC: 2833 Medicinal Chemicals & Botanical Products